APO Research

APO RESEARCH · REPORT

Quick Dissolving Oral Film

Selected research

Industry Research

Quick Dissolving Oral Film Industry Research Report 2026

Market perspective

The global Quick Dissolving Oral Film market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Quick Dissolving Oral Film is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Quick Dissolving Oral Film is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Quick Dissolving Oral Film is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Quick Dissolving Oral Film include Aavishkar, Adhex Pharma, Aquestive Therapeutics, Arx Pharma, BioDelivery(BDSI), Cure Pharmaceutical, IntelGenx Corp., LIVKON Pharmaceutical Pvt Ltd and LLS Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Quick Dissolving Oral Film market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Quick Dissolving Oral Film Market by Company

Aavishkar

Adhex Pharma

Aquestive Therapeutics

Arx Pharma

BioDelivery(BDSI)

Cure Pharmaceutical

IntelGenx Corp.

LIVKON Pharmaceutical Pvt Ltd

LLS Health

Lohmann Therapie-Systeme

NAL Pharma

Shilpa Therapeutics

Tapemark

Umang

ZIM Laboratories

QQP

Xiamen LP Pharma

Top Pharm

Quick Dissolving Oral Film Segment by Type

Medikament Film

Health Products Film

Quick Dissolving Oral Film Segment by Application

Hospital and Clinic

E-commerce Platform

Supermarket and Drug Store

Others

Quick Dissolving Oral Film Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quick Dissolving Oral Film market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quick Dissolving Oral Film and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quick Dissolving Oral Film.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Quick Dissolving Oral Film manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Quick Dissolving Oral Film by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Quick Dissolving Oral Film in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Quick Dissolving Oral Film Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Quick Dissolving Oral Film Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Quick Dissolving Oral Film Sales Market Share by Manufacturers (2021-2026) Table 8. Global Quick Dissolving Oral Film Revenue of Manufacturers (2021-2026) Table 9. Global Quick Dissolving Oral Film Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Quick Dissolving Oral Film Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Quick Dissolving Oral Film Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Quick Dissolving Oral Film, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Quick Dissolving Oral Film, Product Type & Application Table 14. Global Quick Dissolving Oral Film Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Quick Dissolving Oral Film by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Aavishkar Company Information Table 19. Aavishkar Business Overview Table 20. Aavishkar Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Aavishkar Quick Dissolving Oral Film Product Portfolio Table 22. Aavishkar Recent Developments Table 23. Adhex Pharma Company Information Table 24. Adhex Pharma Business Overview Table 25. Adhex Pharma Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Adhex Pharma Quick Dissolving Oral Film Product Portfolio Table 27. Adhex Pharma Recent Developments Table 28. Aquestive Therapeutics Company Information Table 29. Aquestive Therapeutics Business Overview Table 30. Aquestive Therapeutics Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Aquestive Therapeutics Quick Dissolving Oral Film Product Portfolio Table 32. Aquestive Therapeutics Recent Developments Table 33. Arx Pharma Company Information Table 34. Arx Pharma Business Overview Table 35. Arx Pharma Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Arx Pharma Quick Dissolving Oral Film Product Portfolio Table 37. Arx Pharma Recent Developments Table 38. BioDelivery(BDSI) Company Information Table 39. BioDelivery(BDSI) Business Overview Table 40. BioDelivery(BDSI) Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. BioDelivery(BDSI) Quick Dissolving Oral Film Product Portfolio Table 42. BioDelivery(BDSI) Recent Developments Table 43. Cure Pharmaceutical Company Information Table 44. Cure Pharmaceutical Business Overview Table 45. Cure Pharmaceutical Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Cure Pharmaceutical Quick Dissolving Oral Film Product Portfolio Table 47. Cure Pharmaceutical Recent Developments Table 48. IntelGenx Corp. Company Information Table 49. IntelGenx Corp. Business Overview Table 50. IntelGenx Corp. Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. IntelGenx Corp. Quick Dissolving Oral Film Product Portfolio Table 52. IntelGenx Corp. Recent Developments Table 53. LIVKON Pharmaceutical Pvt Ltd Company Information Table 54. LIVKON Pharmaceutical Pvt Ltd Business Overview Table 55. LIVKON Pharmaceutical Pvt Ltd Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. LIVKON Pharmaceutical Pvt Ltd Quick Dissolving Oral Film Product Portfolio Table 57. LIVKON Pharmaceutical Pvt Ltd Recent Developments Table 58. LLS Health Company Information Table 59. LLS Health Business Overview Table 60. LLS Health Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. LLS Health Quick Dissolving Oral Film Product Portfolio Table 62. LLS Health Recent Developments Table 63. Lohmann Therapie-Systeme Company Information Table 64. Lohmann Therapie-Systeme Business Overview Table 65. Lohmann Therapie-Systeme Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lohmann Therapie-Systeme Quick Dissolving Oral Film Product Portfolio Table 67. Lohmann Therapie-Systeme Recent Developments Table 68. NAL Pharma Company Information Table 69. NAL Pharma Business Overview Table 70. NAL Pharma Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. NAL Pharma Quick Dissolving Oral Film Product Portfolio Table 72. NAL Pharma Recent Developments Table 73. Shilpa Therapeutics Company Information Table 74. Shilpa Therapeutics Business Overview Table 75. Shilpa Therapeutics Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Shilpa Therapeutics Quick Dissolving Oral Film Product Portfolio Table 77. Shilpa Therapeutics Recent Developments Table 78. Tapemark Company Information Table 79. Tapemark Business Overview Table 80. Tapemark Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Tapemark Quick Dissolving Oral Film Product Portfolio Table 82. Tapemark Recent Developments Table 83. Umang Company Information Table 84. Umang Business Overview Table 85. Umang Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Umang Quick Dissolving Oral Film Product Portfolio Table 87. Umang Recent Developments Table 88. ZIM Laboratories Company Information Table 89. ZIM Laboratories Business Overview Table 90. ZIM Laboratories Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. ZIM Laboratories Quick Dissolving Oral Film Product Portfolio Table 92. ZIM Laboratories Recent Developments Table 93. QQP Company Information Table 94. QQP Business Overview Table 95. QQP Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. QQP Quick Dissolving Oral Film Product Portfolio Table 97. QQP Recent Developments Table 98. Xiamen LP Pharma Company Information Table 99. Xiamen LP Pharma Business Overview Table 100. Xiamen LP Pharma Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Xiamen LP Pharma Quick Dissolving Oral Film Product Portfolio Table 102. Xiamen LP Pharma Recent Developments Table 103. Top Pharm Company Information Table 104. Top Pharm Business Overview Table 105. Top Pharm Quick Dissolving Oral Film Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Top Pharm Quick Dissolving Oral Film Product Portfolio Table 107. Top Pharm Recent Developments Table 108. Global Quick Dissolving Oral Film Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Quick Dissolving Oral Film Sales by Region (2021-2026) & (K Units) Table 110. Global Quick Dissolving Oral Film Sales Market Share by Region (2021-2026) Table 111. Global Quick Dissolving Oral Film Sales by Region (2027-2032) & (K Units) Table 112. Global Quick Dissolving Oral Film Sales Market Share by Region (2027-2032) Table 113. Global Quick Dissolving Oral Film Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Quick Dissolving Oral Film Revenue Market Share by Region (2021-2026) Table 115. Global Quick Dissolving Oral Film Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Quick Dissolving Oral Film Revenue Market Share by Region (2027-2032) Table 117. North America Quick Dissolving Oral Film Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Quick Dissolving Oral Film Sales by Country (2021-2026) & (K Units) Table 119. North America Quick Dissolving Oral Film Sales by Country (2027-2032) & (K Units) Table 120. North America Quick Dissolving Oral Film Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Quick Dissolving Oral Film Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Quick Dissolving Oral Film Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Quick Dissolving Oral Film Sales by Country (2021-2026) & (K Units) Table 124. Europe Quick Dissolving Oral Film Sales by Country (2027-2032) & (K Units) Table 125. Europe Quick Dissolving Oral Film Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Quick Dissolving Oral Film Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Quick Dissolving Oral Film Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Quick Dissolving Oral Film Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Quick Dissolving Oral Film Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Quick Dissolving Oral Film Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Quick Dissolving Oral Film Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Quick Dissolving Oral Film Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Quick Dissolving Oral Film Sales by Country (2021-2026) & (K Units) Table 134. South America Quick Dissolving Oral Film Sales by Country (2027-2032) & (K Units) Table 135. South America Quick Dissolving Oral Film Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Quick Dissolving Oral Film Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Quick Dissolving Oral Film Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Quick Dissolving Oral Film Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Quick Dissolving Oral Film Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Quick Dissolving Oral Film Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Quick Dissolving Oral Film Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Quick Dissolving Oral Film Sales by Type (2021-2026) & (K Units) Table 143. Global Quick Dissolving Oral Film Sales by Type (2027-2032) & (K Units) Table 144. Global Quick Dissolving Oral Film Sales Market Share by Type (2021-2026) Table 145. Global Quick Dissolving Oral Film Sales Market Share by Type (2027-2032) Table 146. Global Quick Dissolving Oral Film Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Quick Dissolving Oral Film Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Quick Dissolving Oral Film Revenue Market Share by Type (2021-2026) Table 149. Global Quick Dissolving Oral Film Revenue Market Share by Type (2027-2032) Table 150. Global Quick Dissolving Oral Film Price by Type (2021-2026) & (US$/Unit) Table 151. Global Quick Dissolving Oral Film Price by Type (2027-2032) & (US$/Unit) Table 152. Global Quick Dissolving Oral Film Sales by Application (2021-2026) & (K Units) Table 153. Global Quick Dissolving Oral Film Sales by Application (2027-2032) & (K Units) Table 154. Global Quick Dissolving Oral Film Sales Market Share by Application (2021-2026) Table 155. Global Quick Dissolving Oral Film Sales Market Share by Application (2027-2032) Table 156. Global Quick Dissolving Oral Film Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Quick Dissolving Oral Film Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Quick Dissolving Oral Film Revenue Market Share by Application (2021-2026) Table 159. Global Quick Dissolving Oral Film Revenue Market Share by Application (2027-2032) Table 160. Global Quick Dissolving Oral Film Price by Application (2021-2026) & (US$/Unit) Table 161. Global Quick Dissolving Oral Film Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Quick Dissolving Oral Film Distributors List Table 165. Quick Dissolving Oral Film Customers List Table 166. Quick Dissolving Oral Film Industry Trends Table 167. Quick Dissolving Oral Film Industry Drivers Table 168. Quick Dissolving Oral Film Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Quick Dissolving Oral Film Product Image Figure 5. Global Quick Dissolving Oral Film Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Quick Dissolving Oral Film Market Size (2021-2032) & (US$ Million) Figure 7. Global Quick Dissolving Oral Film Sales (2021-2032) & (K Units) Figure 8. Global Quick Dissolving Oral Film Average Price (US$/Unit) & (2021-2032) Figure 9. Medikament Film Product Image Figure 10. Health Products Film Product Image Figure 11. Hospital and Clinic Product Image Figure 12. E-commerce Platform Product Image Figure 13. Supermarket and Drug Store Product Image Figure 14. Others Product Image Figure 15. Global Quick Dissolving Oral Film Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Quick Dissolving Oral Film, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Quick Dissolving Oral Film Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Quick Dissolving Oral Film Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Quick Dissolving Oral Film Sales by Region in 2025 Figure 21. Global Quick Dissolving Oral Film Revenue by Region in 2025 Figure 22. North America Quick Dissolving Oral Film Market Size by Country in 2025 Figure 23. North America Quick Dissolving Oral Film Sales Market Share by Country (2021-2032) Figure 24. North America Quick Dissolving Oral Film Revenue Market Share by Country (2021-2032) Figure 25. United States Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Quick Dissolving Oral Film Market Size by Country in 2025 Figure 29. Europe Quick Dissolving Oral Film Sales Market Share by Country (2021-2032) Figure 30. Europe Quick Dissolving Oral Film Revenue Market Share by Country (2021-2032) Figure 31. Germany Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Quick Dissolving Oral Film Market Size by Country in 2025 Figure 42. Asia Pacific Quick Dissolving Oral Film Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Quick Dissolving Oral Film Revenue Market Share by Country (2021-2032) Figure 44. China Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Quick Dissolving Oral Film Market Size by Country in 2025 Figure 53. South America Quick Dissolving Oral Film Sales Market Share by Country (2021-2032) Figure 54. South America Quick Dissolving Oral Film Revenue Market Share by Country (2021-2032) Figure 55. Brazil Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Quick Dissolving Oral Film Market Size by Country in 2025 Figure 59. Middle East and Africa Quick Dissolving Oral Film Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Quick Dissolving Oral Film Revenue Market Share by Country (2021-2032) Figure 61. Egypt Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Quick Dissolving Oral Film Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Quick Dissolving Oral Film Sales Market Share by Type (2021-2032) Figure 67. Global Quick Dissolving Oral Film Revenue Market Share by Type (2021-2032) Figure 68. Global Quick Dissolving Oral Film Price (US$/Unit) by Type (2021-2032) Figure 69. Global Quick Dissolving Oral Film Sales Market Share by Application (2021-2032) Figure 70. Global Quick Dissolving Oral Film Revenue Market Share by Application (2021-2032) Figure 71. Global Quick Dissolving Oral Film Price (US$/Unit) by Application (2021-2032) Figure 72. Quick Dissolving Oral Film Value Chain Figure 73. Quick Dissolving Oral Film Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Quick Dissolving Oral Film Industry Opportunities and Challenges

Scope & coverage.

Types
  • Medikament Film
  • Health Products Film
Applications
  • Hospital and Clinic
  • E-commerce Platform
  • Supermarket and Drug Store
  • Others
Companies covered
  • Aavishkar
  • Adhex Pharma
  • Aquestive Therapeutics
  • Arx Pharma
  • BioDelivery(BDSI)
  • Cure Pharmaceutical
  • IntelGenx Corp.
  • LIVKON Pharmaceutical Pvt Ltd
  • LLS Health
  • Lohmann Therapie-Systeme
  • NAL Pharma
  • Shilpa Therapeutics
  • Tapemark
  • Umang
  • ZIM Laboratories
  • QQP
  • Xiamen LP Pharma
  • Top Pharm

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Quick Dissolving Oral Film Market Size (2021-2032)
  4. 2.2.2 Global Quick Dissolving Oral Film Sales (2021-2032)
  5. 2.2.3 Global Quick Dissolving Oral Film Market Average Price (2021-2032)
  6. 2.3 Quick Dissolving Oral Film by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Medikament Film
  9. 2.3.3 Health Products Film
  10. 2.4 Quick Dissolving Oral Film by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital and Clinic
  13. 2.4.3 E-commerce Platform
  14. 2.4.4 Supermarket and Drug Store
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Quick Dissolving Oral Film Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Quick Dissolving Oral Film Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Quick Dissolving Oral Film Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Quick Dissolving Oral Film Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Quick Dissolving Oral Film Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Quick Dissolving Oral Film, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Quick Dissolving Oral Film, Product Type & Application
  8. 3.8 Global Manufacturers of Quick Dissolving Oral Film, Established Date
  9. 3.9 Global Quick Dissolving Oral Film Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Aavishkar
  2. 4.1.1 Aavishkar Company Information
  3. 4.1.2 Aavishkar Business Overview
  4. 4.1.3 Aavishkar Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Aavishkar Quick Dissolving Oral Film Product Portfolio
  6. 4.1.5 Aavishkar Recent Developments
  7. 4.2 Adhex Pharma
  8. 4.2.1 Adhex Pharma Company Information
  9. 4.2.2 Adhex Pharma Business Overview
  10. 4.2.3 Adhex Pharma Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Adhex Pharma Quick Dissolving Oral Film Product Portfolio
  12. 4.2.5 Adhex Pharma Recent Developments
  13. 4.3 Aquestive Therapeutics
  14. 4.3.1 Aquestive Therapeutics Company Information
  15. 4.3.2 Aquestive Therapeutics Business Overview
  16. 4.3.3 Aquestive Therapeutics Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Aquestive Therapeutics Quick Dissolving Oral Film Product Portfolio
  18. 4.3.5 Aquestive Therapeutics Recent Developments
  19. 4.4 Arx Pharma
  20. 4.4.1 Arx Pharma Company Information
  21. 4.4.2 Arx Pharma Business Overview
  22. 4.4.3 Arx Pharma Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Arx Pharma Quick Dissolving Oral Film Product Portfolio
  24. 4.4.5 Arx Pharma Recent Developments
  25. 4.5 BioDelivery(BDSI)
  26. 4.5.1 BioDelivery(BDSI) Company Information
  27. 4.5.2 BioDelivery(BDSI) Business Overview
  28. 4.5.3 BioDelivery(BDSI) Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 BioDelivery(BDSI) Quick Dissolving Oral Film Product Portfolio
  30. 4.5.5 BioDelivery(BDSI) Recent Developments
  31. 4.6 Cure Pharmaceutical
  32. 4.6.1 Cure Pharmaceutical Company Information
  33. 4.6.2 Cure Pharmaceutical Business Overview
  34. 4.6.3 Cure Pharmaceutical Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Cure Pharmaceutical Quick Dissolving Oral Film Product Portfolio
  36. 4.6.5 Cure Pharmaceutical Recent Developments
  37. 4.7 IntelGenx Corp.
  38. 4.7.1 IntelGenx Corp. Company Information
  39. 4.7.2 IntelGenx Corp. Business Overview
  40. 4.7.3 IntelGenx Corp. Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 IntelGenx Corp. Quick Dissolving Oral Film Product Portfolio
  42. 4.7.5 IntelGenx Corp. Recent Developments
  43. 4.8 LIVKON Pharmaceutical Pvt Ltd
  44. 4.8.1 LIVKON Pharmaceutical Pvt Ltd Company Information
  45. 4.8.2 LIVKON Pharmaceutical Pvt Ltd Business Overview
  46. 4.8.3 LIVKON Pharmaceutical Pvt Ltd Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 LIVKON Pharmaceutical Pvt Ltd Quick Dissolving Oral Film Product Portfolio
  48. 4.8.5 LIVKON Pharmaceutical Pvt Ltd Recent Developments
  49. 4.9 LLS Health
  50. 4.9.1 LLS Health Company Information
  51. 4.9.2 LLS Health Business Overview
  52. 4.9.3 LLS Health Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 LLS Health Quick Dissolving Oral Film Product Portfolio
  54. 4.9.5 LLS Health Recent Developments
  55. 4.10 Lohmann Therapie-Systeme
  56. 4.10.1 Lohmann Therapie-Systeme Company Information
  57. 4.10.2 Lohmann Therapie-Systeme Business Overview
  58. 4.10.3 Lohmann Therapie-Systeme Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Lohmann Therapie-Systeme Quick Dissolving Oral Film Product Portfolio
  60. 4.10.5 Lohmann Therapie-Systeme Recent Developments
  61. 4.11 NAL Pharma
  62. 4.11.1 NAL Pharma Company Information
  63. 4.11.2 NAL Pharma Business Overview
  64. 4.11.3 NAL Pharma Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 NAL Pharma Quick Dissolving Oral Film Product Portfolio
  66. 4.11.5 NAL Pharma Recent Developments
  67. 4.12 Shilpa Therapeutics
  68. 4.12.1 Shilpa Therapeutics Company Information
  69. 4.12.2 Shilpa Therapeutics Business Overview
  70. 4.12.3 Shilpa Therapeutics Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Shilpa Therapeutics Quick Dissolving Oral Film Product Portfolio
  72. 4.12.5 Shilpa Therapeutics Recent Developments
  73. 4.13 Tapemark
  74. 4.13.1 Tapemark Company Information
  75. 4.13.2 Tapemark Business Overview
  76. 4.13.3 Tapemark Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Tapemark Quick Dissolving Oral Film Product Portfolio
  78. 4.13.5 Tapemark Recent Developments
  79. 4.14 Umang
  80. 4.14.1 Umang Company Information
  81. 4.14.2 Umang Business Overview
  82. 4.14.3 Umang Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Umang Quick Dissolving Oral Film Product Portfolio
  84. 4.14.5 Umang Recent Developments
  85. 4.15 ZIM Laboratories
  86. 4.15.1 ZIM Laboratories Company Information
  87. 4.15.2 ZIM Laboratories Business Overview
  88. 4.15.3 ZIM Laboratories Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 ZIM Laboratories Quick Dissolving Oral Film Product Portfolio
  90. 4.15.5 ZIM Laboratories Recent Developments
  91. 4.16 QQP
  92. 4.16.1 QQP Company Information
  93. 4.16.2 QQP Business Overview
  94. 4.16.3 QQP Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 QQP Quick Dissolving Oral Film Product Portfolio
  96. 4.16.5 QQP Recent Developments
  97. 4.17 Xiamen LP Pharma
  98. 4.17.1 Xiamen LP Pharma Company Information
  99. 4.17.2 Xiamen LP Pharma Business Overview
  100. 4.17.3 Xiamen LP Pharma Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Xiamen LP Pharma Quick Dissolving Oral Film Product Portfolio
  102. 4.17.5 Xiamen LP Pharma Recent Developments
  103. 4.18 Top Pharm
  104. 4.18.1 Top Pharm Company Information
  105. 4.18.2 Top Pharm Business Overview
  106. 4.18.3 Top Pharm Quick Dissolving Oral Film Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Top Pharm Quick Dissolving Oral Film Product Portfolio
  108. 4.18.5 Top Pharm Recent Developments
5 Global Quick Dissolving Oral Film Market Scenario by Region
  1. 5.1 Global Quick Dissolving Oral Film Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Quick Dissolving Oral Film Sales by Region: 2021-2032
  3. 5.2.1 Global Quick Dissolving Oral Film Sales by Region: 2021-2026
  4. 5.2.2 Global Quick Dissolving Oral Film Sales by Region: 2027-2032
  5. 5.3 Global Quick Dissolving Oral Film Revenue by Region: 2021-2032
  6. 5.3.1 Global Quick Dissolving Oral Film Revenue by Region: 2021-2026
  7. 5.3.2 Global Quick Dissolving Oral Film Revenue by Region: 2027-2032
  8. 5.4 North America Quick Dissolving Oral Film Market Facts & Figures by Country
  9. 5.4.1 North America Quick Dissolving Oral Film Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Quick Dissolving Oral Film Sales by Country (2021-2032)
  11. 5.4.3 North America Quick Dissolving Oral Film Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Quick Dissolving Oral Film Market Facts & Figures by Country
  16. 5.5.1 Europe Quick Dissolving Oral Film Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Quick Dissolving Oral Film Sales by Country (2021-2032)
  18. 5.5.3 Europe Quick Dissolving Oral Film Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Quick Dissolving Oral Film Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Quick Dissolving Oral Film Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Quick Dissolving Oral Film Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Quick Dissolving Oral Film Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Quick Dissolving Oral Film Market Facts & Figures by Country
  41. 5.7.1 South America Quick Dissolving Oral Film Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Quick Dissolving Oral Film Sales by Country (2021-2032)
  43. 5.7.3 South America Quick Dissolving Oral Film Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Quick Dissolving Oral Film Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Quick Dissolving Oral Film Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Quick Dissolving Oral Film Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Quick Dissolving Oral Film Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Quick Dissolving Oral Film Sales by Type (2021-2032)
  2. 6.1.1 Global Quick Dissolving Oral Film Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Quick Dissolving Oral Film Sales Market Share by Type (2021-2032)
  4. 6.2 Global Quick Dissolving Oral Film Revenue by Type (2021-2032)
  5. 6.2.1 Global Quick Dissolving Oral Film Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Quick Dissolving Oral Film Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Quick Dissolving Oral Film Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Quick Dissolving Oral Film Sales by Application (2021-2032)
  2. 7.1.1 Global Quick Dissolving Oral Film Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Quick Dissolving Oral Film Sales Market Share by Application (2021-2032)
  4. 7.2 Global Quick Dissolving Oral Film Revenue by Application (2021-2032)
  5. 7.2.1 Global Quick Dissolving Oral Film Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Quick Dissolving Oral Film Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Quick Dissolving Oral Film Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Quick Dissolving Oral Film Value Chain Analysis
  2. 8.1.1 Quick Dissolving Oral Film Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Quick Dissolving Oral Film Production Mode & Process
  5. 8.2 Quick Dissolving Oral Film Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Quick Dissolving Oral Film Distributors
  8. 8.2.3 Quick Dissolving Oral Film Customers
9 Global Quick Dissolving Oral Film Analyzing Market Dynamics
  1. 9.1 Quick Dissolving Oral Film Industry Trends
  2. 9.2 Quick Dissolving Oral Film Industry Drivers
  3. 9.3 Quick Dissolving Oral Film Industry Opportunities and Challenges
  4. 9.4 Quick Dissolving Oral Film Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research